SynthesisFrontiers in immunology2026
Sex and risk of hyperprogressive disease in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
Jia Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.